As of 2024-09-19, the Relative Valuation of Helix Biopharma Corp (HBP.TO) is (0.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.32 CAD, the upside of Helix Biopharma Corp based on Relative Valuation is -100.9%.
The range of the Relative Valuation is (0.01) - (0.04) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 0.3x | 0.1x |
| Forward P/E multiples | 0.1x - 0.3x | 0.1x |
| Fair Price | (0.01) - (0.04) | (0.01) |
| Upside | -100.8% - -102.8% | -100.9% |
| Date | P/E |
| 2024-09-19 | -10.30 |
| 2024-09-18 | -10.06 |
| 2024-09-16 | -10.54 |
| 2024-09-12 | -9.98 |
| 2024-09-11 | -10.54 |
| 2024-09-10 | -10.38 |
| 2024-09-09 | -9.74 |
| 2024-09-05 | -10.38 |
| 2024-09-04 | -10.30 |
| 2024-09-03 | -10.06 |
| 2024-08-30 | -10.06 |
| 2024-08-29 | -9.58 |
| 2024-08-26 | -9.18 |
| 2024-08-23 | -9.58 |
| 2024-08-22 | -9.18 |
| 2024-08-21 | -8.78 |
| 2024-08-20 | -8.46 |
| 2024-08-19 | -9.18 |
| 2024-08-16 | -9.18 |
| 2024-08-15 | -8.78 |
| 2024-08-12 | -8.78 |
| 2024-08-06 | -9.38 |
| 2024-08-02 | -9.18 |
| 2024-08-01 | -9.18 |
| 2024-07-31 | -9.18 |
| 2024-07-26 | -8.98 |
| 2024-07-25 | -10.78 |
| 2024-07-24 | -8.98 |
| 2024-07-23 | -9.18 |
| 2024-07-22 | -9.18 |
| 2024-07-15 | -9.18 |
| 2024-07-12 | -9.18 |
| 2024-07-10 | -9.18 |
| 2024-07-05 | -9.38 |
| 2024-07-04 | -9.38 |
| 2024-07-03 | -9.38 |
| 2024-07-02 | -9.78 |
| 2024-06-27 | -9.38 |
| 2024-06-26 | -9.18 |
| 2024-06-25 | -9.18 |
| 2024-06-24 | -9.18 |
| 2024-06-21 | -9.58 |